XOMA CORPORATION (NASDAQ:XOMA) Files An 8-K Results of Operations and Financial ConditionItem 2.02 Results of Operations and Financial Condition
On August8, 2017, XOMA Corporation issued a press release announcing its financial results for the quarter ended June30, 2017. The full text of the press release issued in connection with the announcement is attached as Exhibit99.1 to this Current Report on Form8-K and is incorporated herein by reference.
The information in this Form8-K and the Exhibitattached hereto shall not be deemed “filed” for purposes of Section18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.
Item 2.02 Financial Statements and Exhibits
(d)Exhibits
|
Number |
DescriptionofDocument |
| 99.1 | Press release entitled “XOMA Reports Second Quarter 2017 Financial Results” dated August8, 2017 |
XOMA Corp ExhibitEX-99.1 2 d437721dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 XOMA Reports Second Quarter 2017 Financial Results Executing new corporate strategy leveraging extensive portfolio of partnered programs Earned $10 million milestone payment from a pharmaceutical partner Reduced combined R&D and G&A expenses 56% year-over-year Current cash balance sufficient to fund operations through August 2018 Berkeley,…To view the full exhibit click here
